Definitive Tumor Directed Therapy for Metachronous Oligometastatic HPV-Associated Oropharyngeal Cancer Following Trans-Oral Robotic Surgery
JournalInternational Journal of Radiation Oncology - Biology - Physics
MetadataShow full item record
AbstractRecent landmark trials have suggested a survival benefit to definitive tumor directed therapies (DTDT) for selected patients with metastatic disease for various malignancies. We sought 1) to confirm the prognostic significance of metachronous oligometastatic burden for human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) and 2) to evaluate disease outcomes for oligometastatic HPV-associated OPSCC after upfront DTDT versus upfront systemic therapy.
Rights/TermsCopyright © 2021 Published by Elsevier Inc.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/18469